Evidence map›Paper›PMID 34405856›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2022

Multi-PheWAS intersection approach to identify sex differences across comorbidities in 59 140 pediatric patients with autism spectrum disorder.

Alba Gutiérrez-Sacristán, Carlos Sáez, Carlos De Niz, Niloofar Jalali, Thomas N DeSain, Ranjay Kumar, Joany M Zachariasse, Kathe P Fox, Nathan Palmer, Isaac Kohane and 1 more

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alba Gutiérrez-SacristánDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-1245-198X
Carlos SáezDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-2678-8249
Carlos De NizDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Niloofar JalaliDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Thomas N DeSainDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Ranjay KumarDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Joany M ZachariasseDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Kathe P FoxDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Nathan PalmerDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Isaac KohaneDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Paul AvillachDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-0235-7543

Funding

TrainingU54HG007963 · NHGRI · HARVARD MEDICAL SCHOOL · PI KOHANE, ISAAC S. · 2014 to 2018
$18.3M
NHGRI NIH HHS U54 HG007963NIH HHS BD2K
6 · The paper itself

Abstract

objectiveTo identify differences related to sex and define autism spectrum disorder (ASD) comorbidities female-enriched through a comprehensive multi-PheWAS intersection approach on big, real-world data. Although sex difference is a consistent and recognized feature of ASD, additional clinical correlates could help to identify potential disease subgroups, based on sex and age. MATERIALS AND

methodsWe performed a systematic comorbidity analysis on 1860 groups of comorbidities exploring all spectrum of known disease, in 59 140 individuals (11 440 females) with ASD from 4 age groups. We explored ASD sex differences in 2 independent real-world datasets, across all potential comorbidities by comparing (1) females with ASD vs males with ASD and (2) females with ASD vs females without ASD.

resultsWe identified 27 different comorbidities that appeared significantly more frequently in females with ASD. The comorbidities were mostly neurological (eg, epilepsy, odds ratio [OR] > 1.8, 3-18 years of age), congenital (eg, chromosomal anomalies, OR > 2, 3-18 years of age), and mental disorders (eg, intellectual disability, OR > 1.7, 6-18 years of age). Novel comorbidities included endocrine metabolic diseases (eg, failure to thrive, OR = 2.5, ages 0-2), digestive disorders (gastroesophageal reflux disease: OR = 1.7, 6-11 years of age; and constipation: OR > 1.6, 3-11 years of age), and sense organs (strabismus: OR > 1.8, 3-18 years of age). DISCUSSION: A multi-PheWAS intersection approach on real-world data as presented in this study uniquely contributes to the growing body of research regarding sex-based comorbidity analysis in ASD population.

conclusionsOur findings provide insights into female-enriched ASD comorbidities that are potentially important in diagnosis, as well as the identification of distinct comorbidity patterns influencing anticipatory treatment or referrals. The code is publicly available (https://github.com/hms-dbmi/sexDifferenceInASD).

Indexed as

Autism Spectrum DisorderSex CharacteristicsChildChild, PreschoolComorbidityFemaleHumansInfantInfant, NewbornMaleOdds RatioPrevalenceautism spectrum disordercomorbiditylarge-scalesex characteristics

Identifiers

PMID34405856
PMCPMC8757290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.